NasdaqCM - Nasdaq Real Time Price USD

Monopar Therapeutics Inc. (MNPR)

39.42
-2.95
(-6.96%)
At close: May 9 at 4:00:01 PM EDT
39.42
0.00
(0.00%)
After hours: May 9 at 4:05:12 PM EDT
All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-6,404.14
-6,404.14
-7,858.29
-7,228.56
-7,317.40
Investing Cash Flow
-14,338.40
-14,338.40
4,927.75
-4,918.51
0
Financing Cash Flow
59,292.26
59,292.26
2,027.23
32.87
10,879.54
End Cash Position
45,816.29
45,816.29
7,266.08
8,186.19
20,303.87
Issuance of Capital Stock
59,396.39
59,396.39
2,074.20
109.34
10,925.31
Issuance of Debt
--
--
--
--
0
Free Cash Flow
-6,404.14
-6,404.14
-7,858.29
-7,228.56
-7,317.40
12/31/2021 - 12/19/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DRUG Bright Minds Biosciences Inc.
32.49
+1.34%
 
PRQR ProQR Therapeutics N.V.
1.6100
+3.87%
 
STOK Stoke Therapeutics, Inc.
9.36
+3.43%
 
DBVT DBV Technologies S.A.
9.83
-0.10%
 
QNRX Quoin Pharmaceuticals, Ltd.
6.19
-3.43%
 
XFOR X4 Pharmaceuticals, Inc.
3.3700
+2.43%
 
LPTX Leap Therapeutics, Inc.
0.3350
-7.23%
 
WVE Wave Life Sciences Ltd.
6.59
+0.69%
 
ACTU Actuate Therapeutics, Inc. Common stock
10.35
+4.55%
 
RYTM Rhythm Pharmaceuticals, Inc.
57.38
-5.50%